This survey is only available to primary

  • Caregivers of children with Cystic Fibrosis aged 12-24 months old and eligible for the medication “Kalydeco” (Ivacaftor).
  • Caregivers of children with Cystic Fibrosis aged 2-5 years, currently taking “Kalydeco” (Ivacaftor).


These will be conducted as 60-minute web-assisted telephone interviews at a time of the participants’ convenience, and for their time and opinions we’re offering an incentive of £70.

CFTechnology will get a donation for referrals.

Please contact us at

[email protected] for the more details!